Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Long shot cheap option .
View:
Post by Galaxym31 on Jun 11, 2024 4:48pm

Long shot cheap option .

Warrants .005 .
Comment by livermore2 on Jun 11, 2024 5:10pm
Could they be one of those yolo trades the Reddit kids talk about? Gamma squeeze perhaps? Doesn't research capital own a bunch of them, with this news of late I'm surprised they don't want them exercised. Time will tell.... lots of market time until august to play around!
Comment by Habeneropie on Jun 11, 2024 5:58pm
I assume the warrants that are trading now all expire in the fall how do people buy and sell the new warrants they keep issuing that are good for another several years? those have to be worth much more one day
Comment by CAinPlap on Jun 11, 2024 6:16pm
The new (non 2018 issued)warrants are not tradeable. The 2024 placements have a 5 year expiry while the ones issued in 2022 and 2023 have a 2 year term. 
Comment by Habeneropie on Jun 11, 2024 8:06pm
Good to know Cain plap  thanks
Comment by Galaxym31 on Jun 11, 2024 9:04pm
Good to August 22 , so time for a run .
Comment by chry200030 on Jun 11, 2024 11:19pm
Yes, buy all you can at half a penny..The stock should have a nice rise before they expire bringing these options into good money.
Comment by steamfitter on Jun 12, 2024 3:09am
 Buy out When someone wants to buy a company out they force the share price down then offer what it has been in the last 30 days plus's a small bonus to sell watch out they are almost there. 
Comment by Oilminerdeluxe on Jun 12, 2024 4:30am
Yeah, let's not hope for a buyout where cents are involved...The BTD, if nothing evil happens, should be here no later than October. Although, we all know delays can always happen. But if it is given then, the value simply must go bananas. Or should anyway. Nothing ever goes as planned, however. I am sure those attending the AGM will give their brief view of things here afterwards, for which I ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250